Evaxion Biotech, a clinical-stage biotech company based in Hørsholm, Denmark, is revolutionizing the field of immunotherapies with its AI-powered platforms. The company’s mission is to decode the human immune system to develop effective immunotherapies for cancer, bacterial diseases, and viral infections.

This technology has enabled them to advance a robust product pipeline through their state-of-the-art platforms in cancer and infectious disease. Their focus is on drug discovery and early drug development, with an eye towards a future that reimagines the way cancer and infectious diseases are treated - and even cured.